177lu-psma-617
novartis
[' vision', 'prostate']
[177lu]lu-psma-617 in psma-positive metastatic castration-resistant prostate cancer: prior and concomitant treatment subgroup analyses of the vision trial #asco22 
Medical Oncologist - Urologic Oncology. Hospital Universitario La Paz - IdiPAZ, Madrid